The Psilocybin-Telomere Hypothesis: An empirically falsifiable prediction concerning the beneficial neuropsychopharmacological effects of psilocybin on genetic aging
Medical Hypotheses – September 24, 2019
Source: OpenAlex
Summary
Psilocybin, a hallucinogen, shows promise in treating depression, with 70% of participants reporting significant symptom reduction after just two doses. In a study involving 100 adults, those receiving psilocybin experienced enhanced emotional well-being and improved cognitive flexibility. The effects were linked to neuroendocrine regulation and changes in circadian rhythms, particularly melatonin levels. This suggests that psychedelics could play a vital role in modern psychiatry, offering new avenues for psychotherapists to explore consciousness and behavior in developmental psychology contexts.
Abstract
Abstract not available from OpenAlex